CHI Podcasts cover art

All Episodes

CHI Podcasts — 255 episodes

#
Title
1

Molecular Med Tri-Con 2020 | Artificial Intelligence in Precision Medicine

2

Molecular Med TriCon 2019 | Gene Therapy for Rare Disorders

3

Immunogenicity Summit 2019 | From Cell & Gene Therapy to Biostatistics

4

Next Generation Dx 2019 | Launch a Paradigm Shift through an Innovative Diagnostic Test

5

the Liquid Biopsy Summit 2019 | Reimagining Liquid Biopsy Applications with Epigenomics

6

Molecular DX Europe 2019 | Using Point-of-Care Diagnostics to Advance a One Health Approach

7

Molecular Med Tri-Con 2019 | Putting the AI in Wait

8

Molecular Med Tri-Con 2019 | Real Precision Medicine is Starting with the Patient

9

Molecular Med Tri-Con 2019 | Target the Tumor Mutational Burden and Pursue Harmonization

10

PEGS Boston 2019 | Jennifer Chadwick’s Story of Building a Creative and Authentic Career in Science

11

Bio-IT World | Advancing Life Sciences Research: Accelerating innovation in the age of cloud

12

Molecular Med Tri-Con 2019 | Personalized Estimation of Motality Risk

13

Information Technology in Support of Genetics in the Clinic

14

Leveraging Health Information Exchange to Achieve Population Health Surveillance

15

Population Segmentation and Care Management in R&D of New Therapeutics

16

Discovery on Target 2018 | Reprogramming Tumor Microenvironment to Enhance Immunotherapy

17

Discovery on Target 2018 | Novel Strategies to Produce Better NK Cells for Cancer Treatment

18

Discovery on Target 2018 | Engineering NK Cells for Enhanced Potency and Persistence

19

PEGS Europe 2018 | Transient Protein Gene Expression and Biotherapeutics

20

Bispecific Antibody Pipeline Congress 2018 | Checkpoint-binding Bispecific Antibodies

21

Next Generation DX Summit 2018 | Challenges and Opportunities in Molecular Testing

22

Next Generation Dx 2018 | Dissecting Liquid Biopsy in MBC

23

Next Generation Dx Summit 2018 | Molecular Diagnostics in Precision Medicine and Healthcare

24

Next Generation DX Summit 2018 | the Value of NGS-based Diagnostic Testing for Lung Cancer Patients

25

Next Generation DX Summit 2018 | Developing Low Cost Diagnostics for Infectious Disease

26

Next Generation DX Summit 2018 | Rapid Fire: Getting to Know Suman Bose

27

Bio-IT World Expo 2018 | AI and Machine Learning for Healthcare

28

Bio-IT World Expo 2018 | Gene Discovery and Clinical Impact

29

Bio-IT World Expo 2018 | High-Speed Scientific Data Transfers, Scalability Impact on Security

30

Molecular Diagnostics Europe 2018 | Advances in Sepsis Diagnostics: the HostDx Sepsis Platform

31

World Preclinical Congress 2018 | Next-Generation Screening Platforms: BBB Organoids and Beyond

32

PEGS Boston 2018 | Building a Single Donor Phage Antibody Library with NGS Validation

33

Molecular Diagnostics Europe 2018 | The Changing Regulatory Requirements in the EU

34

Molecular Diagnostics Europe 2018 | The Role of Epigenetics in Circulating Tumour Cells

35

Molecular Diagnostics Europe 2018 | Addressing Challenges in cfDNA Analysis

36

Harnessing the power of Big Data and AI for faster, better, and more efficient studies

37

PEGS Boston 2018 | Discovery of High-Affinity Human PD-1 and LAG-3 Antibodies

38

Molecular Diagnostics Europe 2018 | Cell-Based NIPD: Where Are We Now and Where Are We Going?

39

Molecular Diagnostics Europe 2018 | The New EU IVD Regulation – What Will It Mean for Your Lab?

40

PEGS Boston 2018 | Challenges and Opportunities in the Next Generation of Bioassays for Biologics

41

PEGS Boston 2018 | How to Interpret and Implement FDA Guidelines for Biologics?

42

PEGS Boston 2018 | An interview with the 2018 Young Scientist Keynote, Dr. Kipp Weiskopf

43

SCOPE 2018 | Clinical Trial Contracting Challenges

44

PepTalk 2018 | Remodeling of Cell Surfaceomes in Cancer

45

ImPACT 2017 | Targeting the Hypoxic Tumor Microenvironment

46

Bio-IT World | Accelerate Real World Evidence: Leveraging Data for Faster Time to Insight

47

ImPACT 2017 | What Will the IMPACT of the Microbiome be on Cancer Immunotherapy?

48

Advances in Prenatal Molecular Diagnostics 2017 | Fetal Whole Exome Sequencing

49

PEGS Europe 2017 | The Next Generation of Antibody-Drug Conjugates (ADCs)

50

Discovery on Target 2017 | Small Molecule Ubiquitin Protease (USP7) Inhibitors

51

Discovery on Target 2017 | Targeted Platform for RNA Therapeutics

52

Discovery on Target 2017 - PROTACs: The Chemical Equivalent of CRISPR

53

Next Generation Dx 2017 | Wild West: Exome Sequencing in the Clinic

54

IMPACT 2017 | Parker Institute for Cancer Immunotherapy -Tumor Epitope Selection Alliance (TESLA)

55

Biobanking Congress 2017 | Biobank Sustainability and the Upstream Impact of Clinical Care

56

Biobanking Congress 2017 | Observations on the Post-Mortem Tissue Donation for Biospecimen Research

57

Next Generation Dx Summit 2017 | Molecular Diagnostics in Antibiotics Stewardships Programs

58

Next Generation Dx Summit 2017 | Point-of-Care Devices in Immunotherapy and Beyond

59

Next Generation Dx Summit 2017 | Point-of-Care Devices in Liquid Biopsy

60

Molecular Med Tri-Con 2017 | Development of Novel Diagnostic Tests

61

Molecular Med Tri-Con 2017 | Diagnostics World Early Innovator Award Interview

62

Next Generation Dx Summit 2017 | The Microbiome’s Diagnostic Potential

63

Next Generation Summit 2017 | NGS in DNA Forensics: Benefits, Challenges, and Future Potential

64

World Preclinical Congress 2017 | Need for Translational Methods in CNS Drug Discovery

65

Next Generation Dx Summit 2017 | Predicting Responses to Cancer Immunotherapy

66

Next Generation Dx Summit 2017 | Geisinger’s Strategy for Clinical NGS Implementation

67

Next Generation Dx Summit 2017 | Precision Medicine Outside of Oncology

68

Next Generation Dx Summit 2017 | Implementing Point-of-Care Testing and Pharmacogenetic Testing

69

Next Generation Dx Summit 2017 | Genome Sequencing Clinical Applications

70

Next Generation Dx Summit 2017 | Reimbursement of Companion Diagnostics

71

Next Generation Dx Summit 2017 | Walking Down Evidence Street™: Where the Market Meets Evidence

72

World Preclinical Congress 2017 | Next-Generation Human Body-on-a-Chip Systems

73

Biodefense World Summit 2017 | Empowering Rapid Diagnostics with Sample Preparation Methodologies

74

PEGS Boston 2017 | Generation of BiKEs and TriKEs

75

Molecular Med Tri-Con 2017 | Targeted NGS Panel in Autism Spectrum Disorders

76

World Preclinical Congress 2017 | Cancer Therapeutics – Advice for the Future

77

Strategic Alliance Management Congress 2017 | The Evolution and Challenges of Biopharma Alliances

78

Medical Informatics World 2017 | Leveraging Novel Technologies to Improve Patient Access

79

Bio-IT World Expo 2017 | Data Security Standards for Drug R&D

80

Liquid Biopsy Summit 2017 | Cancer Metastasis

81

PEGS Boston 2017 | Development on Novel Therapeutic Antibodies

82

Bio-IT World | Strategic Challenges in the Bio IT Infrastructure Landscape

83

Medical Informatics World 2017 | What Is Necessary to make Telehealth Standard of Care?

84

World Preclinical Congress 2017 | Developing Microfluidics

85

PEGS Boston 2017 | Future Directions for HX-MS in Formulation Development and Similarity Assessment

86

Bio-IT World Expo 2017 | Genomic Medicine: Bioinformatics, Whole Genomes and the Future of the Field

87

Clinical Trial Innovation Summit 2017 | The Need for Collaboration and Performance Metrics

88

Molecular Diagnostics Europe 2017 | Immune Monitoring in Next Generation Immunotherapy Trials

89

Clinical Trial Innovation Summit 2017 | Lessons Learned from a Pharma and CRO Perspective

90

PEGS Boston 2017 | New Technology on Multiplex ADA Isotyping

91

Bio-IT World Expo 2017 | The Future of IT in the World of Big Data

92

PEGS Boston 2017 | Preventing Toxicity in CAR T Cell Therapy

93

Molecular Med Tri-Con 2017 | NIPT: Ethical Implications and Trends Toward Precision Medicine

94

PEGS Boston 2017 | The Promise of Neoantigens for Personalized Cancer Vaccines

95

Molecular Med Tri-Con 2017 | Early Detection of Cancer: Myth or Reality?

96

PEGS Boston 2017 | Programming Proteins by Deep Sequencing and Design

97

Bio-IT World 2017 | Scalable Systems for Data Visualization: Current and Future Challenges

98

Molecular Diagnostics Europe 2017 | Redefining the Set of Solutions for Antibiotics Misuse

99

Molecular Diagnostics Europe 2017 | Point-of-Impact Testing in the Emergency Department

100

Molecular Med Tri-Con 2017 | The Future of Bioinformatics in Personalized & Precision Medicine

101

Molecular Diagnostics Europe 2017 | Early Detection of Cancer: Myth or Reality?

102

Molecular Med Tri-Con 2017 | Using Big Data to Create Better Precision Medicine

103

SCOPE 2017 | Clinical Trials: Patient Centricity and Wearables

104

SCOPE 2017 | Managing Precision Medicine Clinical Trials

105

PepTalk 2017 | From Protein Science R&D to Therapeutics: Expert Insights (Part 2)

106

PepTalk 2017 | From Protein Science R&D to Therapeutics: Expert Insights (Part 1)

107

Discovery on Target 2016 | Advances and Challenges in Histone Demethylase Inhibitors

108

PEGS Europe 2016 | Evolution of Recombinant Protein Expression

109

Biobanking Congress 2016 | Biobanking Quality Control and Centralization

110

Biobanking Congress 2016 | Sample Preprocessing, Circulating Nucleic Acids, and Clinical Data

111

Biobanking Congress 2016 | PDX Models and Biobanking for Preclinical Drug Development

112

Next Generation Dx Summit 2016 | Combining Whole Genome Sequencing with Clinical Care

113

Next Generation Dx Summit 2016 | Transitioning Basic Research Into Actual Diagnostics

114

PEGS Europe 2016 | Immune Checkpoint in Melanoma

115

Next Generation Dx Summit 2016 | Digital PCR Changing the Way Scientists Conduct Research

116

PEGS Europe 2016 | Display and Signaling of CAR Molecules

117

Next Generation Summit DX 2016 | NGS Pricing and Precision Medicine Implementation in the Clinic

118

World Preclinical Congress 2016 | Immunosequencing for Cancer Immunotherapy Development

119

Bio-IT World Expo 2016 | Visualizing Genomic Data: Spotlight on IOBIO

120

Next Generation Dx Summit 2016 | The Microbiome and Human Reproduction

121

World Preclinical Congress 2016 | Microfluidic 3D Cell Cultures and Organ Models for Drug Testing

122

Liquid Biopsy Summit 2016 | The Potential of Extracellular RNAs

123

World Preclinical Congress 2016 | A Conversation on Modern Lead Generation Strategies

124

World Preclinical Congress 2016 | Challenges and Future Directions of Blood-Brain Barrier Research

125

Bioprocessing Summit 2016 | Applications of AU-FDS to High-Concentration Antibody Interactions

126

Liquid Biopsy Summit 2016 | Molecular Diagnostics and Liquid Biopsy Sample Prep

127

World Preclinical Congress 2016 | Animal Models and Combination Therapy

128

Strategic Alliance Management Congress 2016 | Sponsor-CRO Strategic Partnerships

129

Molecular Diagnostics Europe 2016 | Ethical Challenges in Preimplantation Testing: What’s Next?

130

Bio-IT World Expo 2016 | Sharing Genetic Data in Clinics, Ethics and Pediatrics

131

Molecular Diagnostics Europe 2016 | Cell-free DNA Prenatal Testing

132

Molecular Diagnostics Europe 2016 | Advances in NIPT Technology at Sequenom

133

Bio-IT World 2016 | Improving Clinical Research and Patient Care with Health Informatics

134

Oligonucleotide Theapeutics & Delivery 2016 | The Resurgence of Oligonucleotide Therapeutics

135

PEGS Boston 2016 | Phenotypic Screening for Novel Antibody Targets in the Tumor Microenvironment

136

Molecular Med Tri-Con 2016 | Next-Generation Sequencing for Detecting Antimicrobial Resistance

137

Molecular Diagnostics Europe 2016 | The Clinical Implication of Liquid Biopsies

138

Tri-Con 2016 | Metabolomics for Sepsis: Predictive Biomarkers

139

Molecular Diagnostics Europe 2016 | Mitochondrial DNA

140

Molecular Diagnostics Europe 2016 | Implementation of POCT Quality Standards

141

PepTalk 2016 | Every Protein Is Different: Difficult Targets, GPCRs and Drug Discovery

142

Advances in Prenatal Molecular Diagnostics 2015 | Cell-free DNA Prenatal Testing

143

Reproductive Genetic Diagnostics 2015 | The Latest Technologies for PGD Testing

144

PEGS Europe 2015 | CHO Cells and Recombinant Protein Production across Expression Platforms

145

Reproductive Genetic Diagnostics 2015 | Genetic Diagnostics for Recurrent Pregnancy Loss

146

Discovery on Target 2015 | Targeting The Unfolded Protein Response

147

Bonus Podcast: Histone Methyltransferase and Demethylase Inhibitor Discovery

148

Discovery on Target 2105 | Histone Methyltransferase and Demethylase Inhibitor Discovery

149

Next Generation Dx Summit 2015 | Blood-Based Genotyping of Colorectal Cancer Patients

150

Next Generation Dx Summit 2015 | Metabolomics for Infectious Disease: A Focus on Sepsis

151

Next Generation Dx Summit 2015 | Biomarkers for Infectious Disease

152

Biobanking Congress 2015 | Rapid Tissue Procurement and Robust Biospecimen Data for Cancer Research

153

Next Generation Dx Summit 2015 | Technological Advancements for Diagnostics Sequencing

154

Discovery on Target 2015 | Targeting DUBs

155

Biobanking Congress 2015 | The Best Biobank Is an Empty Biobank

156

Next Generation Dx Summit 2015 | POC in the Pharmacy: Practical, Legal, and Future Perspectives

157

Sample Prep Technologies 2015 | Sample Preparation and Specimen Quality for NGS assays

158

Chemical Biology for Target Validation 2015 | Targeting the Stress Chaperome in Cancer

159

Strategic Alliance Management Congress 2015 | Setting a New Standard in Alliance Management

160

PEGS Boston 2015 | Identification and Translation of Optimal Immunotherapy Combinations

161

The Clinical Genome Conference 2015 | Returning Genomic Incidental Findings to Patients

162

World Preclinical Congress 2015 | Tissue Stem Cells, Tumors, Toxicity and Time

163

Bio-IT World 2015 | Life Sciences IT Risk Management, Cloud Security and Regulatory Compliance

164

WPC 2015 | Pain and the Brain: Using Patient-Derived Neurons for Preclinical Phenotypic Screening

165

TCGC 2015 | Driven by “Why”: Genomic Complexity, Public Engagement and Data Management

166

Molecular DX Europe 2015 | COLD-PCR for Liquid Biopsy: Current Impact and Future Directions

167

TCGC 2015 | Breast Cancer Genomics, Predictive Data and Therapy Guidance

168

Bio-IT World 2015 | The Genomics Data Privacy Landscape

169

PEGS Boston 2015 | Analytical Technologies for Characterizing Circulating ADC Species

170

PEGS China 2015 | Synthetic Antibodies for Ebola Virus Immunotherapy and Research

171

Bio-IT 2015 | Health IT Compliance, Data Security Risk Management and Regulations

172

MDXE 2015 | How Will the New Regulation Change the IVD Landscape in Europe

173

BioIT World 2015 | Applying Data Science, Bioinformatics and Networks to Cancer Genomics

174

Next Generation Summit 2015 | Point-of-Care Diagnostics in CVS' MinuteClinics

175

SCOPE 2015 | Effective Patient Engagement and Education for Clinical Trials

176

SCOPE 2015 | Postmarketing Regulatory Environment in Europe

177

MMTC 2015 | The Future of Digital Pathology

178

MMTC 2015 | Inaugural Swimming with the Sharks Competition

179

SCOPE 2015 | Managing Drug Safety Challenges from Clinical Trials to Post Marketing Stages

180

PepTalk 2015 | Strategies for Cross the Blood-Brain Barrier with Antibody Therapeutics

181

PepTalk 2015 | Baculovirus-Insect Cell Systems for Protein Production

182

PepTalk 2015 | CHO Cells and Computational Models for Recombinant Protein Expression

183

PepTalk 2015 | Enabling High-Throughput Protein Expression

184

PepTalk 2015 | Leachables and Extractables: Updates, Best Practices and Recommendations

185

PepTalk 2015 | Analytical Control Strategy for Novel Complex Recombinant Biotherapeutics

186

EBRS 2014 | Impact of PAMA on the Molecular Diagnostics Market Environment

187

EBRS 2014 | Reimbursement and Adoption of Personalized Genomic Medicine

188

FAST Congress 2014 | Understanding Drug Toxicity

189

Discovery On Target 2014 | Development of Histone Demethylase Inhibitors

190

FAST Congress 2014 | “Sci-Fi Come to Life”

191

Anti-Bacterial Drug Development Summit 2014 | Developing Robust Platforms

192

Anti-Bacterial Drug Development Summit 2014 | New Antibiotic Commercialization

193

Discovery On Target 2014 | Targeting BET Bromodomains in Cancer

194

BioBanking and Cancer at the Crossroads 2014 | Impact of Biobanks and Fit-for-Purpose Biospecimens

195

Cancer Diagnosis at the Crossroads 2014 | Clinical Applications of NGS Gene Panels

196

BioBanking and Cancer Diagnosis Podcast 2014 | Precise Cancer Surgeries and Drug Treatments

197

Next Generation Summit 2014 | Preview of the Panel Discussion on IMPLEMENTATION OF MOLECULAR TESTING

198

BioBanking and Cancer Diagnosis Podcast 2014 | The Business of Biobanking

199

Next Generation Summit 2014 | Companion Diagnostics

200

Next Generation Summit 2014 | Single-Cell Sequencing and Complex Cancer Genome Analysis

201

Next Generation Summit 2014 | Single-Cell Genomic Sequencing: Improvements, Challenges and Utility

202

Next Generation Summit 2014 | The “Safety” of Genomic Testing

203

Next Generation Summit 2014 | Integration of Genomics into Medical Practice: Educational Challenges

204

Discovery On Target 2014 | Opportunities and Challenges with Developing Small Molecule Inhibitors

205

Strategic Alliance Management Congress 2014 | The Impact of Academic-Industry Alliances

206

The Clinical Genome Conference 2014 | Impact on Research and Interpretation of Results

207

The Clinical Genome Conference 2014 | Reimbursement of Clinical Sequencing Tests for Patient Care

208

Structure-Based Drug Design and Target Validation 2014 | New Targets for Drug Discovery

209

The Clinical Genome Conference 2014 | Translation of Genomic Data

210

PEGS 2014 | In vivo Selection of Antibodies

211

World Pharma Congress 2014 | Using in vitro Data to Reduce Animal Experiments

212

PEGS 2014 | Smart Strategies for Developing Bispecifics, Combinations and Mixture of Antibodies

213

Property Based Drug Design 2014 | Physicochemical Properties in Designing Better Drug Candidates

214

PEGS 2014 | Novel Engineering Solutions for Potent Bispecific Antibodies

215

Drug Discovery Chemistry 2014 | Discovery to Clinic - A Medicinal Chemist's Perspective

216

World Pharma Congress 2014 | Chemical Route Development of HCV Protease-Inhibitor

217

Drug Discovery Chemistry 2014 | The Future of Fragments and PPIs

218

BioIT World Expo 2014 | Cloud Computing, Genomic Data Analysis and Clinical Validation

219

Structure-Based Drug Design 2014 | Using Structure and Property-Based Methods

220

BioIT World Expo 2014 | Identifying Functional Elements of the Human Genome

221

BioIT World Expo 2014 | Systems Pharmacology Approaches for Drug and Cancer Research

222

World Pharma Congress 2014 | Routes toward DPP-IV Inhibitor Compounds

223

World Pharma Congress 2014 | Development of Poorly Soluble Drug

224

BioIT World Expo 2014 | Data Sharing and Security for Pharma and Life Science

225

BioIT World Expo 2014 | Large-Scale Data Management for Reproducible Life Science Research

226

BioIT World Expo 2014 | Computational Modeling for CNS Drug Research and Clinical Trial Design

227

PepTalk 2014 | Toxicological Risk Assessment of Extractables and Leachables

228

PepTalk 2014 | Single-Use Bioreactors and Impact on Cell Culture Performance

229

PepTalk 2014 | Process Analytical Technologies for Freezing and Primary Drying of Biologics

230

PepTalk 2014 | Large Volume Injectors for Subcutaneous Delivery

231

PepTalk 2014 | BPOG’s Extractable Protocol Standardization Journey

232

PepTalk 2014 | Protein Aggregation and Emerging Tools

233

PepTalk 2014 | Emerging Drying Technologies

234

PepTalk 2014 | Protein Expression and Biological Engineering

235

PepTalk 2014 | Unfolded Protein Response: Pathways to Recombinant Protein Production

236

Molecular Med Tri-Con 2014 | Microfluidics for Mobile Diagnostics

237

PepTalk 2014 | Cellular Biology, Biotechnology and Recombinant Protein Production

238

PepTalk 2014 | Efficient Protein Expression and Engineered Bacteria

239

Clinical Genomics Podcast | Genetic Analysis of Cancer

240

Clinical Genomics Podcast | Public Health Genomics, Data and Ethics

241

Molecular Med Tri-Con 2014 | Enabling Physician Use of Genomic Data Through Cloud-Based Software

242

Clinical Genomics Podcast | Genetics and the Public

243

PepTalk 2014 | Simplifying Genomics and Optimizing Protein Expression

244

Clinical Genomics Podcast | The Importance of RNA-Sequencing

245

Clinical Genomics Podcast | IT Infrastructures for Genomic Data Management and Clinical Practice

246

Clinical Genomics Podcast | Cloud Computing and Storage for Genomic Research and the Clinic

247

SCOPE Podcast | Clinical Trial Biospecimen Management & Working Effectively with a Central Lab

248

Molecular Med Tri-Con 2014 | PCR Technologies

249

Clinical Genomics Podcast | Highlights from the Upcoming Clinical Exome Sequencing Conference

250

BioBanking Podcast | Biospecimen Research and the Cohorts Biorepository

251

BioBanking Podcast | Sample Acquisition and Management: Biobanking Regulations and Improvements

252

BioBanking Podcast | Biobanking and Biopreservation: The Promise, Problems and Solutions

253

FAST Congress Podcast | Bioengineering Tissues and Organs: Materials, Interactions and Predictions

254

FAST Congress Podcast | 3-D Tissue Engineering: Methods, Challenges and Possibilities

255

FAST Congress Podcast | 3-D Cell Culture Systems: Understanding Interactions and Aiding Research